ORX:STO
Orexo AB
SEKÂ 1.37
arrow_downward
-1.58%(-0.022) Siku 1
6 Nov, 17:29:49 GMT +1 · SEK
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ORX...
Fungua
SEKÂ 1.47
Juu
SEKÂ 1.47
Chini
SEKÂ 1.31
Mtaji wa soko
48.05M
Wastani wa kiasi cha mauzo
elfu 320.60
Kiasi cha mauzo ya hisa
elfu 525.28
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.06
Juu kwa wiki 52
SEKÂ 36.00
Chini kwa wiki 52
SEKÂ 1.30
EPS
SEKÂ 21.73
Hisa za wawekezaji
35.13M
Idadi ya wafanyakazi
55
Fungua
SEKÂ 1.47
Juu
SEKÂ 1.47
Chini
SEKÂ 1.31
Mtaji wa soko
48.05M
Wastani wa kiasi cha mauzo
elfu 320.60
Kiasi cha mauzo ya hisa
elfu 525.28
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.06
Juu kwa wiki 52
SEKÂ 36.00
Chini kwa wiki 52
SEKÂ 1.30
EPS
SEKÂ 21.73
Hisa za wawekezaji
35.13M
Idadi ya wafanyakazi
55
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Foreign Policy Journal
·
saa 1 iliyopita
Microsoft's (NASDAQ: MSFT) $677 Billion Backlog Signals AI Ambition As Capex Surges And Neocloud Ties Fray
BigGo Finance
·
dakika 20 zilizopita
Goldman Sachs Panic Index Breaches Extreme 9.5 Threshold; History Shows S&P 500 Averaged 4.6% Gain Over Following Three Months
Seoul Economic Daily
·
saa 1 iliyopita
Half S&P 500, Half Short-Term Treasuries: Counted as a 'Safe Asset' Under Retirement-Account Rules
Yahoo Finance
·
saa 3 zilizopita
Forget the High-Beta Hype: 5 ‘Sleep Well at Night’ Stocks to Buy Now
Wasifu
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Kuhusu Orexo AB
Afisa Mkuu Mtendaji (CEO)Nikolaj Sørensen
Wafanyakazi55
Lilianzishwa1995
Makao makuu-
SektaHealth Care
Sekta-
Tovutiorexo.com